Faculty profile

Martin Pelchat

Back to faculty

Associate ProfessorBiochemistry, Microbiology and ImmunologyUniversity of Ottawa

Martin Pelchat

Associate Professor

Biochemistry, Microbiology and Immunology

Faculty of Medicine

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
16 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 4 research grants (4 NSERC), most recently in 2023.
Supervised 1 trainee who won CIHR awards, most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Latest papers

Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort
Vaccine · 2026
Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
Microgravity-induced immune dysregulation: phase-specific profiles of differential gene expression.
Biochemistry and cell biology = Biochimie et biologie cellulaire · 2025 · first author

All 39 publications

Latest funding

Empowering Large-Scale Infectious Disease Research and Mobilizing Knowledge: The Serology and Diagnostics High-Throughput Platform as Critical Research Infrastructure for Pandemic Preparedness, Surveillance, and Response in Canada
CIHR · 2025 · Co-investigator
$2,999,998
Molecular and Antibody Surveillance of H5N1 in Animals and Humans using a High Throughput Diagnostic Platform
CIHR · 2024 · Co-investigator
$150,000
Involvement of RNA polymerase II in transcription of RNA viruses
NSERC · 2023 · Principal investigator
$80,000

All 11 grants and awards

39 publications.

Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort

Azeez R, Ames SR, Lotoski LC, Winsor GL, Arnold CR, Galipeau Y, Pelchat M, Goguen S, Simons E, Moraes TJ

Vaccine2026

DOI: 10.1016/j.vaccine.2026.128342

Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection.

Galipeau Y, Castonguay N, McCluskie PS, Sonoda MT, Keeshan A, Collins E, Arnold C, Pelchat M, Burns K, Cooper C, Langlois MA

FASEB journal : official publication of the Federation of American Societies for Experimental Biology2025

DOI: 10.1096/fj.202402694r PMID: 39950298

Microgravity-induced immune dysregulation: phase-specific profiles of differential gene expression.

Pelchat M, Trudel G, Rocheleau L, Stratis D, Laneuville O

Biochemistry and cell biology = Biochimie et biologie cellulaire2025First author

DOI: 10.1139/bcb-2025-0136 PMID: 41055278

The Space Omics and Medical Atlas (SOMA) and international astronaut biobank.

Overbey EG, Kim J, Tierney BT, Park J, Houerbi N, Lucaci AG, Garcia Medina S, Damle N, Najjar D, Grigorev K, Afshin EE, Ryon KA, Sienkiewicz K, Patras L, Klotz R, Ortiz V, MacKay M, Schweickart A, Chin CR, Sierra MA, Valenzuela MF, Dantas E, Nelson TM, Cekanaviciute E, Deards G, Foox J, Narayanan SA, Schmidt CM, Schmidt MA, Schmidt JC, Mullane S, Tigchelaar SS, Levitte S, Westover C, Bhattacharya C, Lucotti S, Wain Hirschberg J, Proszynski J, Burke M, Kleinman AS, Butler DJ, Loy C, Mzava O, Lenz J, Paul D, Mozsary C, Sanders LM, Taylor LE, Patel CO, Khan SA, Suhail Mohamad M, Byhaqui SGA, Aslam B, Gajadhar AS, Williamson L, Tandel P, Yang Q, Chu J, Benz RW, Siddiqui A, Hornburg D, Blease K, Moreno J, Boddicker A, Zhao J, Lajoie B, Scott RT, Gilbert RR, Lai Polo SH, Altomare A, Kruglyak S, Levy S, Ariyapala I, Beer J, Zhang B, Hudson BM, Rininger A, Church SE, Beheshti A, Church GM, Smith SM, Crucian BE, Zwart SR, Matei I, Lyden DC, Garrett-Bakelman F, Krumsiek J, Chen Q, Miller D, Shuga J, Williams S, Nemec C, Trudel G, Pelchat M, Laneuville O, De Vlaminck I, Gross S, Bolton KL, Bailey SM, Granstein R, Furman D, Melnick AM, Costes SV, Shirah B, Yu M, Menon AS, Mateus J, Meydan C, Mason CE

Nature2024

DOI: 10.1038/s41586-024-07639-y PMID: 38862028

Transcriptomic evidence of erythropoietic adaptation from the International Space Station and from an Earth-based space analog.

Trudel G, Stratis D, Rocheleau L, Pelchat M, Laneuville O

NPJ microgravity2024

DOI: 10.1038/s41526-024-00400-9 PMID: 38740795

Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.

Collins E, Galipeau Y, Arnold C, Bhéreur A, Booth R, Buchan AC, Cooper C, Crawley AM, McCluskie PS, McGuinty M, Pelchat M, Rocheleau L, Saginur R, Gravel C, Hawken S, Langlois MA, Little J

Frontiers in public health2024

DOI: 10.3389/fpubh.2024.1276391 PMID: 38784593

The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study.

Almeida ND, Schiller I, Ke D, Sakr E, Plesa M, Vanamala S, Moneger AL, Bazan M, Lucchesi C, Wozniak N, Fritz JH, Piccirillo CA, Pelchat M, Arnold C, Galipeau Y, McCluskie PS, Langlois MA, Dasgupta K, Mazer BD

Frontiers in immunology2024

DOI: 10.3389/fimmu.2024.1330549 PMID: 38433831

Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals.

Whelan M, Galipeau Y, White-Al Habeeb N, Konforte D, Abou El Hassan M, Booth RA, Arnold C, Langlois MA, Pelchat M

Open forum infectious diseases2023Senior author

DOI: 10.1093/ofid/ofad384 PMID: 37547857

The transcriptome response of astronaut leukocytes to long missions aboard the International Space Station reveals immune modulation.

Stratis D, Trudel G, Rocheleau L, Pelchat M, Laneuville O

Frontiers in immunology2023

DOI: 10.3389/fimmu.2023.1171103 PMID: 37426644

The Characteristic Response of the Human Leukocyte Transcriptome to 60 Days of Bed Rest and to Reambulation.

Stratis D, Trudel G, Rocheleau L, Pelchat M, Laneuville O

Medicine and science in sports and exercise2023

DOI: 10.1249/mss.0000000000003071 PMID: 36251376

Empowering Large-Scale Infectious Disease Research and Mobilizing Knowledge: The Serology and Diagnostics High-Throughput Platform as Critical Research Infrastructure for Pandemic Preparedness, Surveillance, and Response in Canada

Co-investigatorCIHR2025Operating Grant: Pandemic Research Platforms Interim Funding - General

Principal investigators: Langlois, Marc-Andre

Keywords: Antibodies; Clinical Trials For Vaccines; Elisa; Emerging Infectious Diseases; High Throughput Automation; Knowledge Mobilization; Molecular Diagnostics; Pandemic Preparedness; Qpcr; Sero-Surveillance (Population-Level)

$2,999,998

Molecular and Antibody Surveillance of H5N1 in Animals and Humans using a High Throughput Diagnostic Platform

Co-investigatorCIHR2024Catalyst Grant: Avian Influenza OneHealth Research

Principal investigators: Langlois, Marc-Andre

Keywords: H5n1; High Throughput Automation; Highly Pathogenic Avian Influenza (Hpai); Molecular Detection (Pcr, Qpcr); One Health; Serosurveillance And Antibody Testing; Surrogate Viral Neutralizing Assay; Surveillance Study

$150,000

Involvement of RNA polymerase II in transcription of RNA viruses

Principal investigatorNSERC2023Discovery Grants Program - Individual

Principal investigators: Pelchat, Martin

Keywords: Bioinformatics; Hepatitis delta virus; High-throughput sequencing; Influenza A virus; Quasispecies; RNA metabolism; RNAP II promoter-proximal pausing; RNA structure and function; Transcription; virus-host interaction

$80,000

Pushing RNA polymerase II transcription: How HDV might hold the key to new antiviral therapies

SupervisorCIHR2021Doctoral Research Award: Canada Graduate Scholarships

Principal investigators: Whelan, Marilyn

Keywords: Hepatitis Delta Virus; Hiv; Influenza; Molecular Biology; Nelf; Rna Polymerase Ii; Viral Infections; Viral Reservoirs

$105,000

Rapid Research Response to the 2019 Novel Coronavirus Outbreak: Development of Targeted Diagnostics, Therapeutics and Comparative Pathogenicity Assessment

Co-investigatorCIHR2020Operating Grant: COVID-19 - Diagnostics

Principal investigators: Langlois, Marc-Andre

Keywords: 2019-Ncov; Coronavirus; Covid-19; Diagnostics; Mers; Pathogenicity; Sars; Sars-Cov-2; Vaccine; Viral Evolution

$999,999

Uncovering the unexpected role of LTR promoter mutations in HIV-1 latency

Co-investigatorCIHR2019Project Grant

Principal investigators: Langlois, Marc-Andre

Keywords: Apobec3; Hiv; Latency; Mutations

$784,125

Uncovering the Unexpected Role of APOBEC3 Mutagenesis in HIV-1 Latency

Co-investigatorCIHR2018Project Grant - Priority Announcement - HIV/AIDS

Principal investigators: Langlois, Marc-Andre

Keywords: Apobec3; Hiv Latency; Latency Reversal; Molecular Virology

$100,000

Characterization of the RNA-protein interactions involved in the replication of Subviral RNAs

Principal investigatorNSERC2015Discovery Grants Program - Individual

Principal investigators: Pelchat, Martin

$180,000

Molecular characterization of interactions between subviral RNAs and their hosts

Principal investigatorNSERC2010Discovery Grants Program - Individual

Principal investigators: Pelchat, Martin

$135,000

A liquid scintillation counter for biochemical research

Co-investigatorNSERC2009Research Tools and Instruments - Category 1 (<$150,000)

Principal investigators: Baenziger, John

$44,556

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Martin Pelchat

Research

Latest papers

Latest funding

Predictors of SARS-CoV-2 anti-Spike IgG antibody levels following two COVID-19 vaccine doses among children and adults in the Canadian CHILD Cohort

Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection.

Microgravity-induced immune dysregulation: phase-specific profiles of differential gene expression.

The Space Omics and Medical Atlas (SOMA) and international astronaut biobank.

Transcriptomic evidence of erythropoietic adaptation from the International Space Station and from an Earth-based space analog.

Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.

The effect of dose-interval on antibody response to mRNA COVID-19 vaccines: a prospective cohort study.

Cross-sectional Characterization of SARS-CoV-2 Antibody Levels and Decay Rates Following Infection of Unvaccinated Elderly Individuals.

The transcriptome response of astronaut leukocytes to long missions aboard the International Space Station reveals immune modulation.

The Characteristic Response of the Human Leukocyte Transcriptome to 60 Days of Bed Rest and to Reambulation.

Empowering Large-Scale Infectious Disease Research and Mobilizing Knowledge: The Serology and Diagnostics High-Throughput Platform as Critical Research Infrastructure for Pandemic Preparedness, Surveillance, and Response in Canada

Molecular and Antibody Surveillance of H5N1 in Animals and Humans using a High Throughput Diagnostic Platform

Involvement of RNA polymerase II in transcription of RNA viruses

Pushing RNA polymerase II transcription: How HDV might hold the key to new antiviral therapies

Rapid Research Response to the 2019 Novel Coronavirus Outbreak: Development of Targeted Diagnostics, Therapeutics and Comparative Pathogenicity Assessment

Uncovering the unexpected role of LTR promoter mutations in HIV-1 latency

Uncovering the Unexpected Role of APOBEC3 Mutagenesis in HIV-1 Latency

Characterization of the RNA-protein interactions involved in the replication of Subviral RNAs

Molecular characterization of interactions between subviral RNAs and their hosts

A liquid scintillation counter for biochemical research

Frequent collaborators

Guy Trudel

Padmaja Subbarao

Curtis Cooper

Shelly Bolotin

Raphael Saginur

Ronald Booth

Padmaja Subbarao

Jean-Philippe Gouin

Marc-André Langlois

Benoit Chabot

Samira Mubareka

Julian Little

Kaberi Dasgupta

Darwyn Kobasa

Deborah Mcneil

Steven Hawken

Kevin Burns

John Kim

Kaberi Dasgupta

Leslie Roos

Deborah Mcneil

Michaeline McGuinty